Home > Clinical Trials
Check All Search

Saved trials

Terminated
NCT01339026
Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention
44 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Cardiovascular Disease
Acute Coronary Syndrome
Completed
NCT02243137
Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate
30 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Adverse Effect of Antithrombotic Drugs
Completed
NCT00166036
Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells
36 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
Diabetes Mellitus
Metabolic Syndrome X
Hypercholesterolemia
Completed
NCT02229773
Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 1464 (Tablet) in Hyperlipemic Healthy Male Subjects
100 Enrollment(s)
0 Study location(s)
Interventional (Phase I)
Healthy
Unknown status
NCT02221102
Edoxaban for TIA and Acute Minor Stroke
3,700 Enrollment(s)
1 Study location(s)
Interventional (Phase II|Phase III)
Ischemia
Stroke
Cerebral Infarction
Completed
NCT01839968
Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel
32 Enrollment(s)
1 Study location(s)
Observational
Acquired Platelet Disorder
Completed
NCT01602913
Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
1 Enrollment(s)
0 Study location(s)
Observational
Depression, Postpartum
Completed
NCT02045966
Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects
16 Enrollment(s)
0 Study location(s)
Interventional (Phase I)
Hepatitis C